Edmonds, WA, United States of America

Sam Sk Lee

This inventor holds 1 USPTO granted patent and 1 published patent application and 6 EPO patents. Top assignee: Cocrystal Pharma, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sam Sk Lee. Retrieved from https://idiyas.com/inventor/sam-sk-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sam Sk Lee: Innovator in Pharmaceutical Development

Introduction

Sam Sk Lee is a notable inventor based in Edmonds, WA (US). He is currently associated with Cocrystal Pharma, Inc., a company focused on developing innovative antiviral therapeutics. Despite having no patents to his name, his contributions to the field of pharmaceuticals are significant.

Latest Patents

As of now, Sam Sk Lee holds 1 patents. However, his work in the pharmaceutical industry continues to influence the development of new treatments.

Career Highlights

Sam has dedicated his career to advancing pharmaceutical research. His role at Cocrystal Pharma, Inc. involves collaborating with a team of experts to explore novel therapeutic approaches. His commitment to innovation in drug development is evident in his professional endeavors.

Collaborations

Sam works alongside talented colleagues such as Tianjing Zhao and Liang Mao. Together, they contribute to the research and development efforts at Cocrystal Pharma, Inc.

Conclusion

In summary, Sam Sk Lee is an influential figure in the pharmaceutical industry, dedicated to advancing antiviral therapeutics through his work at Cocrystal Pharma, Inc. His collaborative efforts with his colleagues highlight the importance of teamwork in driving innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…